DCLK1过表达促进结直肠癌血管生成的作用
该研究基于TCGA和GTEx数据库泛癌分析及结肠癌细胞系体外实验,探讨DCLK1对结肠癌血管生成的影响及分子机制。结果显示DCLK1在结肠癌中表达上调,高表达与较差生存、更晚T分期、淋巴结转移及血管生成正相关,体外实验证实过表达DCLK1增强血管生成能力。
要点
- DCLK1在结肠癌中表达上调,高表达与总生存和疾病特异性生存较差相关。
- DCLK1高表达与更晚T分期、淋巴结转移及血管生成正相关。
- 过表达DCLK1的结肠癌细胞体外血管生成能力增强。
核心结论
- DCLK1通过调控多种分子及通路促进结肠癌血管生成。
研究设计与样本
- 基于TCGA和GTEx数据库进行DCLK1泛癌分析并分析结肠癌预后与血管生成相关性。
- 通过质粒瞬转构建DCLK1敲低SW480和过表达HCT116细胞系,行蛋白芯片测序及通路分析。
- 使用结肠癌组织芯片行多色荧光染色,并通过血管生成实验评估DCLK1对血管生成能力的影响。
主要发现
- DCLK1在结肠癌等多癌种中表达上调(均P<0.05)。
- DCLK1高表达与较差总生存(HR=1.739,95%CI:1.051~2.876,P=0.029)和疾病特异性生存(HR=2.482,95%CI:1.283~4.804,P=0.005)有关。
- 结肠癌中DCLK1高表达者T分期更晚(T3/4 vs T1/2,P=0.011)且多伴淋巴结转移(N1/2 vs N0,P=0.011)。
- DCLK1高表达与结肠癌血管生成正相关(r=0.459,P<0.001),与CD31、CD34、ENG、VWF、VEGFC、VEGFR2正相关(均P<0.001)。
- 组织芯片多色荧光染色显示结肠癌组织中DCLK1与CD31协同表达上调,体外过表达DCLK1的结肠癌细胞血管生成能力更强(P<0.001)。
临床怎么用
- DCLK1高表达可作为结肠癌预后不良及血管生成活跃的潜在生物标志物。
- DCLK1及相关血管生成通路分子或为结肠癌抗血管生成治疗的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect of Doublecortin-like kinase 1 (DCLK1) on the angiogenic capacity of colon cancer SW480 and HCT116 cells and its underlying molecular mechanism. Methods: A pan-cancer analysis of DCLK1 was performed based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. The correlations between DCLK1 expression level in colon cancer and tumor angiogenesis as well as patient prognosis were further analyzed. DCLK1-knockdown SW480 and DCLK1-overexpressing HCT116 cell lines were constructed via plasmid transient transfection. Protein microarray sequencing was used to detect changes in the expression of angiogenesis-related proteins and to conduct pathway analysis. A colon cancer tissue microarray[purchased from Shanghai Xinchao Biotechnology Co., Ltd. (Shanghai, China) in 2025] was subjected to multiplex fluorescent staining to observe the expression relationship between DCLK1 and vascular endothelial marker molecules. The effect of DCLK1 on angiogenic ability was evaluated through an angiogenesis assay. Results: Database analysis revealed that DCLK1 expression was upregulated in colon cancer and multiple other cancer types (all P<0.05). High DCLK1 expression was associated with poorer overall survival (HR=1.739, 95% CI: 1.051-2.876, P=0.029) and disease-specific survival (HR=2.842, 95% CI: 1.283-4.804, P=0.005) in patients. In colon cancer, patients with high DCLK1 expression had more advanced T stage (T3/4 vs. T1/2, P=0.011), more frequent lymph node metastasis (N1/2 vs. N0, P=0.011), and DCLK1 expression was significantly positively correlated with angiogenesis in colon cancer (r=0.459, P<0.001). DCLK1 expression levels showed significant positive correlations with vascular endothelial marker genes CD31, CD34, ENG, VWF, VEGFC, and VEGFR2 (all P<0.001). KEGG and Gene Set Enrichment Analysis (GSEA) showed that DCLK1 co-expressed genes were significantly enriched in pathways related to angiogenesis. Multiplex fluorescence staining of the tissue microarray demonstrated upregulated co-expression of DCLK1 and CD31 in colon cancer tissues. In vitro experiments confirmed that colon cancer cells overexpressing DCLK1 exhibited enhanced angiogenic capacity (P<0.001). Conclusion: DCLK1 promotes angiogenesis in colon cancer by regulating multiple molecules and pathways. 目的: 探讨双肾上腺素皮质样激酶1(DCLK1)对结肠癌细胞SW480和HCT116血管生成能力的影响及其分子机制。 方法: 基于癌症基因组图谱数据库和基因型-组织表达数据库对DCLK1进行单基因泛癌分析,进一步分析结肠癌DCLK1表达水平与肿瘤血管生成和患者预后的相关性。通过质粒瞬转技术构建DCLK1敲低的SW480细胞系、DCLK1过表达的HCT116细胞系,利用蛋白芯片测序技术检测血管生成相关蛋白的表达变化并进行通路分析。使用结肠癌组织芯片(2025年购自上海芯超生物科技有限公司)进行多色荧光染色,观察DCLK1与血管内皮标志分子的表达关系,通过血管生成实验评估DCLK1对血管生成能力的影响。 结果: 数据库分析显示,DCLK1在结肠癌等多癌种中表达上调(均P<0.05),且DCLK1高表达与患者较差的总生存时间(HR=1.739,95% CI:1.051~2.876,P=0.029)和疾病特异性生存时间(HR=2.482,95% CI:1.283~4.804,P=0.005)有关。在结肠癌中,DCLK1高表达者T分期更晚(T3/4期对比T1/2期,P=0.011)、多伴随淋巴结转移(N1/2 对比N0,P=0.011),DCLK1高表达与结肠癌血管生成呈正相关(r=0.459,P<0.001)。DCLK1表达水平与血管内皮标志基因CD31、CD34、ENG、VWF、VEGFC、VEGFR2呈正相关(均P<0.001)。京都基因和基因组数据库及基因集(合)富集分析分析显示,DCLK1共表达基因显著富集于与血管生成相关通路中。组织芯片多色荧光染色显示,结肠癌组织中DCLK1与CD31协同表达上调。体外实验证实,过表达DCLK1的结肠癌细胞具有更强的血管生成能力(P<0.001)。 结论: DCLK1通过调控多种分子及通路促进结肠癌血管生成。.
引用
- Wang S, Yan R, Feng LW, et al. [Role of DCLK1 overexpression in promoting angiogenesis in colorectal cancer]. Zhonghua Zhong Liu Za Zhi. 2026. PMID: 42927947. doi:10.3760/cma.j.cn112152-20251103-00547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。